Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 22Unknown 3Terminated 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Dermatologic 3

Conditions

Keratosis, Actinic 3Uterine Cervical Dysplasia 2Glioblastoma 2Pigmentation Disorders 1Neoplasms 1Melanoma 1Hemangioma, Capillary 1Glioma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms 1Brain Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

Aminolevulinic Acid 4Imiquimod 3Photochemotherapy 2Fluorouracil 2methyl 5-aminolevulinate 1calcipotriene 1Solutions 1Laser Therapy 1LEO 43204 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Keratosis, Actinic × Imiquimod × Clear all
NCT04809662 2024-11-07

Comparing Immune Responses to Topical Imiquimod

University of California, Davis

Terminated
6 enrolled
Dermatologic

Keratosis, Actinic

NCT01538901 2017-09-12

AKtransplant

Medical University of Vienna

Phase 4 Terminated
10 enrolled
Dermatologic

Keratosis, Actinic

NCT01203878 2014-12-08

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Tennessee Clinical Research Center

Phase 4 Terminated
21 enrolled 10 charts
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡